In vivo experiments of tumor-bearing animal models showed that the tumor growth rate and volume of the CD46 interference group were significantly lower than those of the control group (P < 0.01), indicating that the expression of LC3B and ATG5 on the surface of the interference CD46 tumor was increased. This evidence concerns the gene MAP1LC3B and neoplasm.